Sea You at Fetch Long Beach
Logo Image
|Videos|September 13, 2016

Canine lymphoma update

You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in the treatment of lymphoma in your canine veterinary patients.

Cancer. One word guaranteed to sober any veterinary exam room. But a new weapon of mass destruction just aimed its sights on one of the most common forms of canine cancer, lymphoma, as veterinary oncologist Dr. Sue Ettinger told us at CVC Virginia Beach in May. Used in conjunction with chemotherapy, monoclonal antibody therapy (e.g. Blontress-Aratana) flags cancer cells so the dog's immune system can attack them. Hear more:

Related to this article

View more
Laverdia now available for purchase for dogs with lymphoma
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Read more
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Read more